Mohammad Ghanbari is a PhD candidate in Genetics at the University of Tabriz, Iran, focusing on cancer genetics and epigenetics. He earned his MSc in Genetics from the same institution, where his dissertation explored MLL2 gene expression in breast cancer patients. Mohammad also holds a BSc in Biology from Payame Noor University. His research interests span cancer genetics, neurogenetics, and gene therapy. Proficient in various software tools and languages, he is skilled in DNA/RNA extraction, PCR techniques, and more. 🌟🧬📚
Education 🎓
Mohammad Ghanbari is currently a PhD candidate in Genetics at the University of Tabriz, Iran (Sept. 2020 – Present). He completed his MSc in Genetics at the same university in July 2017, with a dissertation titled “Study of MLL2 gene expression changes in patients with breast cancer.” He earned his BSc in Biology from Payame Noor University, Tabriz branch, Iran, in December 2015.
Research Interests 🔬
His research interests include Cancer Genetics, Cancer Epigenetics, Signaling Pathways, Neurogenetics, and Gene Therapy.
Skills 🛠️
- Computer Skills 💻: Proficient with both Macintosh and Windows operating systems. Basic knowledge of R programming. Intermediate skills in SPSS, and experience with GraphPad Prism, Oligo7, SPDBV, Endnote, Gene Runner, Image J, Cytoscape, and Corel Draw.
- Language Skills 🗣️: MSRT score of 60/100; good command of oral and written English.
- Laboratory Skills 🔬: Experienced in DNA and RNA extraction, Polymerase Chain Reaction (PCR), Reverse Transcription-PCR (RT-PCR), and Real-time PCR.
Professional Development
Mohammad Ghanbari, currently a PhD candidate in Genetics at the University of Tabriz, has built a robust foundation in cancer genetics and epigenetics through his MSc and BSc studies. His dissertation on MLL2 gene expression in breast cancer highlights his focus on critical cancer research. He has developed valuable skills in various software tools, including SPSS and GraphPad Prism, and laboratory techniques like PCR and real-time-PCR. His proficiency in these areas enhances his ability to contribute to advancements in cancer and neurogenetics. 📈🧪🧠
Research Focus
Mohammad Ghanbari’s research focus encompasses cancer genetics, cancer epigenetics, and neurogenetics. His work is particularly centered on understanding gene expression changes in cancer, with a special interest in signaling pathways and gene therapy. His expertise in these areas supports innovative approaches to cancer treatment and genetic research. 🧬🔍🎗️
publications:
- Downregulation of miR-29a as a Possible Diagnostic Biomarker for Schizophrenia
- Year: 2024
- Journal: Molecular Biology Reports 🧬
- Authors: Khosroshahi, P.A., Ashayeri, H., Ghanbari, M., Farhang, S., Haghi, M.
- An Updated Review on the Significance of DNA and Protein Methyltransferases and De-methylases in Human Diseases: From Molecular Mechanism to Novel Therapeutic Approaches
- Year: 2024
- Journal: Current Medicinal Chemistry 🔬
- Authors: Ghanbari, M., Khosroshahi, N.S., Alamdar, M., Feizi, M.A.H., Haghi, M.
- Prognostic Value of LncRNA KRT18P55 in Patients with Intestinal Type of Gastric Cancer
- Year: 2022
- Journal: Journal of Gastrointestinal Cancer 🏥
- Authors: Tayefeh-Gholami, S., Ghanbari, M., Aghazadeh, A., Farsad-Akhtar, N., Safaralizadeh, R.
- Ectopic Expression of lncRNA MVIH as a Potential Diagnostic Biomarker in Cervical Cancer
- Year: 2022
- Journal: Genes and Cancer 🧬
- Authors: Ghanbari, M., Aghazadeh, A., Malekabbaslou, E., Saber, A., Safaralizadeh, R.
- Effects of Hyperthermia on TRPV1 and TRPV4 Channels Expression and Oxidative Markers in Mouse Brain
- Year: 2021
- Journal: Cellular and Molecular Neurobiology 🧠
- Authors: Aghazadeh, A., Feizi, M.A.H., Fanid, L.M., Ghanbari, M., Roshangar, L.
- Interleukin-1 in Obesity-Related Low-Grade Inflammation: From Molecular Mechanisms to Therapeutic Strategies
- Year: 2021
- Journal: International Immunopharmacology 🧬
- Authors: Ghanbari, M., Momen Maragheh, S., Aghazadeh, A., Dastmalchi, N., Safaralizadeh, R.
- A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
- Year: 2019
- Journal: Current Cancer Therapy Reviews 🎗️
- Authors: Ghanbari, M., Safaralizadeh, R., Mohammadi, K.